Lensar (LNSR) Income from Continuing Operations (2019 - 2026)
Lensar (LNSR) reported Income from Continuing Operations of 2239000.0 for Q1 2026, up 138.67% year-over-year from 938114.91 in Q1 2025, and up 145.52% quarter-over-quarter from 4919000.0 in Q4 2025.
Lensar (LNSR) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Income from Continuing Operations data on file, last reported at 2239000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 2239000.0, up 138.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 16549000.0 (down 21.64% YoY), and the FY2025 annual result was 24578000.0, down 130.45% from the prior year.
- Income from Continuing Operations advanced to 2239000.0 in Q1 2026 per LNSR's latest filing, from 4919000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 2239000.0 in Q1 2026 and troughed at 7580000.0 in Q3 2025.
- A 5-year average of 3847647.06 and a median of 4083000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2025 and 2026: Income from Continuing Operations sank 508.84% in 2025, then surged 138.67% in 2026.
- A 5-year view of Income from Continuing Operations shows it stood at 2613000.0 in 2022, then retreated by 13.32% to 2961000.0 in 2023, then surged by 56.43% to 1290000.0 in 2024, then plunged by 281.32% to 4919000.0 in 2025, then soared by 145.52% to 2239000.0 in 2026.
- Business Quant data shows LNSR's Income from Continuing Operations at 2239000.0 in Q1 2026, 4919000.0 in Q4 2025, and 7580000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | 2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.24 Mn |
| Dec 31, 2025 | -4.92 Mn |
| Sep 30, 2025 | -7.58 Mn |
| Jun 30, 2025 | -6.29 Mn |
| Mar 31, 2025 | -5.79 Mn |
| Dec 31, 2024 | -1.29 Mn |
| Sep 30, 2024 | -1.25 Mn |
| Jun 30, 2024 | -5.28 Mn |
| Mar 31, 2024 | -2.85 Mn |
| Dec 31, 2023 | -2.96 Mn |
| Sep 30, 2023 | -2.04 Mn |
| Jun 30, 2023 | -2.87 Mn |
| Mar 31, 2023 | -4.36 Mn |
| Dec 31, 2022 | -2.61 Mn |
| Sep 30, 2022 | -4.08 Mn |
| Jun 30, 2022 | -6.80 Mn |
| Mar 31, 2022 | -6.68 Mn |
| Dec 31, 2021 | -3.91 Mn |
| Sep 30, 2021 | -6.17 Mn |
| Jun 30, 2021 | -4.38 Mn |